Form
SCHEDULE 13D/A
Active or control-oriented beneficial ownership filing.
venBio Global Strategic Fund, L.P. - 02 Feb 2026 SCHEDULE 13D/A Report for ALX ONCOLOGY HOLDINGS INC Common Stock, par value $0.001 per share (ALXO)
- Filing manager
- venBio Global Strategic Fund, L.P.
- Reporting owner
- GOODMAN COREY S
- Beneficially owned shares
- 13,163,549 shares
- Large-stake signal
-
Ownership
10%Beneficial ownership of this reported class.
Shares
13,163,549 sharesShares beneficially owned as disclosed.
Event date
02 Feb 2026Date tied to the ownership event or amendment.
Accepted by SEC
04 Feb 2026EDGAR acceptance date.
How to read this large-stake filing
- Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
- Compare this filing with the holder history and issuer page before treating the percentage as a current position.
- Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
- Class ownership
- 10%
- Symbol
- ALXO
- Shares outstanding
- 131,635,490 shares
- SEC form
- SCHEDULE 13D/A
- Accepted by SEC
- 04 Feb 2026, 21:03:01 UTC
- Event date
- 02 Feb 2026
- Source filing
- View source filing
Ownership signal
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Subject security
Names, identifiers, and filing context for this profile.
2 source fields
Source evidence
Original filing metadata and source links for verification.
4 source fields
Key filing fact
venBio Global Strategic Fund, L.P. disclosed 10% ownership in ALX ONCOLOGY HOLDINGS INC Common Stock, par value $0.001 per share (ALXO) on 02 Feb 2026.
Key facts
- venBio Global Strategic Fund, L.P. filed SCHEDULE 13D/A for ALX ONCOLOGY HOLDINGS INC Common Stock, par value $0.001 per share (ALXO).
- Disclosed ownership: 10%.
- Date of event: 02 Feb 2026.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 04 Feb 2026, 21:03.
Research use
- This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
- Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.
Evidence
Backed by Schedule 13D/13G
View source filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Disclosed reporting parties (8)
Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares owned | Sole voting power | Shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| venBio Global Strategic Fund, L.P. | 3.4% | 4,431,600 | 0 | 4,431,600 | /s/ David Pezeshki | David Pezeshki, as attorney-in-fact for Corey Goodman and Robert Adelman, Directors of the General Partners | 0001504130 |
| venBio Global Strategic Fund II L.P. | 6.4% | 8,453,038 | 0 | 8,453,038 | /s/ David Pezeshki | David Pezeshki, as attorney-in-fact for Corey Goodman and Robert Adelman, Directors of the General Partners | 0001634632 |
| venBio Global Strategic GP, L.P. | 3.4% | 4,431,600 | 0 | 4,431,600 | /s/ David Pezeshki | David Pezeshki, as attorney-in-fact for Corey Goodman and Robert Adelman, Directors of the General Partner | 0001770834 |
| venBio Global Strategic GP II, L.P. | 6.4% | 8,453,038 | 0 | 8,453,038 | /s/ David Pezeshki | David Pezeshki, as attorney-in-fact for Corey Goodman and Robert Adelman, Directors of the General Partner | 0001729409 |
| venBio Global Strategic GP, Ltd. | 3.4% | 4,431,600 | 0 | 4,431,600 | /s/ David Pezeshki | David Pezeshki, as attorney-in-fact for Corey Goodman and Robert Adelman, Directors | 0001770835 |
| venBio Global Strategic GP II, Ltd. | 6.4% | 8,453,038 | 0 | 8,453,038 | /s/ David Pezeshki | David Pezeshki, as attorney-in-fact for Corey Goodman and Robert Adelman, Directors | 0001729408 |
| Adelman Robert J | 9.9% | 12,984,044 | 99,406 | 12,884,638 | /s/ David Pezeshki | David Pezeshki, as attorney-in-fact | 0001329161 |
| GOODMAN COREY S | 10% | 13,163,549 | 111,541 | 13,052,008 | /s/ David Pezeshki | David Pezeshki, as attorney-in-fact | 0001278411 |
CIK / CUSIP context first